Kane Biotech Inc. (TSX-V:KNE) ("Kane Biotech", "Kane" or the "Company") today announces its first quarter 2025 financial results. First Quarter 2025 ...

Despite regulation changes in the Chinese healthcare industry, we think CSPC is well-positioned to maintain relatively strong revenue growth. First, generic drugs normally face the most severe price ...

CPHI & PMEC China will be returning to the Shanghai New International Expo Center from June 24-26 amid a marked surge in international interest, with industry momentum rebounding following a string of ...

Such deals allow Chinese firms to profit while minimising capital outlays, but also carry risks, law firm says.

Dow gains 117 points as Nvidia jumps 3.2% on strong earnings; court halts Trump's reciprocal tariffs; biotech leads sector gains while bond yields fall.

The pups, some as young as eight months, were “reused” and then “euthanized” if they suffered organ dysfunction, were ...

Notably, the U.S.’ two primary biopharma trade groups—the Pharmaceutical Research and Manufacturers of America (PhRMA) and ...

Under the deal, announced on May 20, Pfizer gains the opportunity to develop and sell the SSGJ-707 drug in markets outside of ...

In a letter to the Department of Commerce, Novo Nordisk argued that unsanctioned compounded semaglutide, mostly from China, ...

In this era of escalating trade tensions and geopolitical uncertainty, the U.S. cannot afford to cede another critical ...

Nearly a third of employed and almost half of unemployed BioSpace survey respondents are seriously considering leaving the ...

China is now setting the pace in life sciences R&D, conducting more clinical trials than the U.S. and licensing new ...